Photodynamic Diagnostic D-Light C System
Karl Storz Endoscopy-America, Inc. · Decision date Jul 21, 2026
What did the FDA decide?
FDA records P050027/S036 as a supplement to PMA P050027, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 21, 2026.
FDA approval order statement
for the use of an automatic pneumatic Loctite applicator and new holding fixture. The change is being made to standardize the delivery of Loctite onto the grasping mechanism screws of the Image1 S HX-P Saphira Camera Head
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Jul 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P050027/S036
- Regulatory pathway
- PMA supplement
- Applicant
- Karl Storz Endoscopy-America, Inc.
- Product code
- OAY
- Decision code
- OK30
- Decision date
- Jul 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light source system, diagnostic endoscopic.
- Applicant
- Karl Storz Endoscopy-America, Inc.
- Product code
- OAY
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P050027. Subsequent supplements may change the device or its indications.
FDA decision timeline
P050027 · Original PMA
KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM
P050027/S034 · Related supplement
Photodynamic Diagnostic D-Light C System
P050027/S035 · Related supplement
Photodynamic Diagnostic D-Light C (PDD) System
P050027/S036 received
Application receipt date recorded by FDA.
P050027/S036 · FDA decision
30-Day Notice
P050027/S038 · Related supplement
Photodynamic Diagnostic D-Light C System
Timeline entries are records held by MedtechLedger for P050027. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P050027
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Karl Storz Endoscopy-America, Inc. | PMA approval | May 28, 2010 | FDA | |
Photodynamic Diagnostic D-Light C SystemP050027/S034 | Karl Storz Endoscopy-America, Inc. | PMA supplement | Oct 1, 2025 | FDA |
Photodynamic Diagnostic D-Light C (PDD) SystemP050027/S035 | Karl Storz Endoscopy-America, Inc. | PMA supplement | Feb 26, 2026 | FDA |
Photodynamic Diagnostic D-Light C SystemP050027/S038 | Karl Storz Endoscopy-America, Inc. | PMA supplement | Oct 14, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Karl Storz Endoscopy-America, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 2151 E. Grand Ave., El Segundo, CA, 90245
Sources and methodology
- Original FDA record: P050027/S036
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


